The inhibitors blunt FAK Try-397 auto-phosphorylation and affects downstream signaling pathways including PI3K/AKT, STAT3 and JNK in some cancer cells, and further influence cell viability, proliferation, migration, and immunosuppressive TME (Zhang et al., 2014; Hirt et al., 2018). The gene discussed is PTK2; the disease is cancer.